Back to FMR LLC FMR LLC

ELVNELVN
Showing 8 of 14 quarters

Position history for FMR LLCFMR LLC's holdings in ENLIVEN THERAPEUTICS INC

Yes. FMR holds 10,025,017 shares of ELVN (Enliven Therapeutics), worth $508.8M, as of its Q2 2026 13F filing. It increased the position by 3,195,771 shares (+46.8%) from Q1 2026. FMR has held ELVN in every 13F on record since Q1 2023, 14 quarterly filings.

Current Value

$508.8M

Current Shares

10M

Total Value Change

+$348M

Total Shares Change

+3.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
10M
+46.8%
$508.8M0.0%$50.75
43
2026-Q1
Decreased
6.8M
-3.9%
$267.7M0.0%$28.75
0
2025-Q4
Decreased
7.1M
-0.3%
$109.5M0.0%$15.55
0
2025-Q3
Decreased
7.1M
-5.7%
$145.9M0.0%$20.30
0
2025-Q2
Increased
7.6M
+14.4%
$151.7M0.0%$20.68
35
2025-Q1
Increased
6.6M
+1.8%
$130.1M0.0%$21.07
31
2024-Q4
Increased
6.5M
+3.2%
$146.2M0.0%$22.50
31
2024-Q3
Increased
6.3M
+10.6%
$160.8M0.0%$25.54
34

Other major holders of ELVN: Polar Capital Holdings Plc, BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used